- Home
- BSET vs ELDN Comparison
BSET vs ELDN Comparison
Compare BSET & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- ELDN
- Stock Information
- Founded
- BSET 1902
- ELDN 2004
- Country
- BSET United States
- ELDN United States
- Employees
- BSET N/A
- ELDN N/A
- Industry
- BSET Home Furnishings
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- BSET Consumer Discretionary
- ELDN Health Care
- Exchange
- BSET Nasdaq
- ELDN Nasdaq
- Market Cap
- BSET 138.2M
- ELDN 164.1M
- IPO Year
- BSET 1987
- ELDN N/A
- Fundamental
- Price
- BSET $15.24
- ELDN $3.44
- Analyst Decision
- BSET
- ELDN Strong Buy
- Analyst Count
- BSET 0
- ELDN 2
- Target Price
- BSET N/A
- ELDN $12.50
- AVG Volume (30 Days)
- BSET 33.7K
- ELDN 1.4M
- Earning Date
- BSET 10-08-2025
- ELDN 11-11-2025
- Dividend Yield
- BSET 5.25%
- ELDN N/A
- EPS Growth
- BSET N/A
- ELDN N/A
- EPS
- BSET 0.90
- ELDN 0.21
- Revenue
- BSET $330,953,000.00
- ELDN N/A
- Revenue This Year
- BSET $3.16
- ELDN N/A
- Revenue Next Year
- BSET $3.59
- ELDN N/A
- P/E Ratio
- BSET $17.00
- ELDN $16.22
- Revenue Growth
- BSET N/A
- ELDN N/A
- 52 Week Low
- BSET $13.58
- ELDN $2.32
- 52 Week High
- BSET $19.75
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- BSET 41.06
- ELDN 71.04
- Support Level
- BSET $15.29
- ELDN $2.58
- Resistance Level
- BSET $15.86
- ELDN $2.71
- Average True Range (ATR)
- BSET 0.62
- ELDN 0.22
- MACD
- BSET -0.04
- ELDN 0.05
- Stochastic Oscillator
- BSET 3.15
- ELDN 77.87
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.